Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson’s disease based on integrative analysis

31 May 2023

Abstract excerpt

Parkinson's disease (PD) is one of the most prevalent movement disorders and its diagnosis relies heavily on the typical clinical manifestations in the late stages. This study aims to screen and identify biomarkers of PD for earlier intervention. We performed a differential analysis of postmortem brain transcriptome studies. Weighted Gene Co-expression Network Analysis (WGCNA) was used to identify biomarkers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments
Share to RNA regulation and disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37258507
DOI: 10.1038/s41531-023-00527-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson’s disease based on integrative analysisPMID 37258507Read ↗

Differential gene expression and immune profiling in Parkinson’s disease: unveiling potential candidate biomarkersSemantic proximity Read ↗

Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's diseaseSemantic proximity Read ↗

Integrative Analysis of Gene Expression Profiles of Substantia Nigra Identifies Potential Diagnosis Biomarkers in Parkinson's diseaseSemantic proximity Read ↗

WGCNA and multiple machine learning methods identified SV2C and DENR as novel biomarkers for Parkinson's diseaseSemantic proximity Read ↗

Identification of ferroptosis related biomarkers and immune infiltration in Parkinson’s disease by integrated bioinformatic analysisSemantic proximity Read ↗

Integrated Analysis of Single-Cell RNA Sequencing and Transcriptome Data Identifies a Pyroptosis-Associated Diagnostic Model for Parkinson’s DiseaseSemantic proximity Read ↗

Parkinson’s Disease Gene Biomarkers Screened by the LASSO and SVM AlgorithmsSemantic proximity Read ↗

Identification of potential diagnostic biomarkers for Parkinson's diseaseSemantic proximity Read ↗

Substantia nigra and blood gene signatures and biomarkers for Parkinson’s disease from integrated multicenter microarray-based transcriptomic analysesSemantic proximity Read ↗

Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson’s diseaseSemantic proximity Read ↗

Identifying MSMO1, ELOVL6, AACS, and CERS2 related to lipid metabolism as biomarkers of Parkinson's diseaseSemantic proximity Read ↗

Bioinformatics identification of potential biomarkers and therapeutic targets for Parkinson's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.